China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Prospective, Non-Interventional Observational Study of Bevacizumab-Containing Regimens Combined with Hyperthermia for Multiple Cancer Types'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131857
Registration Time: 2026/09/07
Type: Observational study
Primary Sponsor: People's Hospital of Zhengzhou
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341955
Published by HT Digital Content Services with permission from Health Daily Digest....